Hyzaar


Also found in: Dictionary.

Hyzaar

(hī′zär′)
A trademark for a drug containing a combination of losartan potassium and hydrochlorothiazide.

Hyzaar®

Losartan K+-hydrochlorothizide, see there.
References in periodicals archive ?
Global sales of Merck's antihypertensive medicines COZAAR and HYZAAR were down 27 percent to $295 million in the third quarter of 2012 due to the loss of market exclusivity in the United States and major European markets in 2010.
Results from a new study with COZAAR and HYZAAR have countered a traditionally held belief that African Americans might not be responsive to recently developed antihypertensives.
Global sales of Merck's antihypertensive medicines COZAAR and HYZAAR declined 26 percent to $315 million in the fourth quarter and 23 percent to $1.
Combination drugs include Aldoril, Atacand HCT, Avalide, Benicar HCT, Diovan HCT, Dyazide, Hyzaar, Lotensin HCT, Maxzide, Micardis HCT.
In 2009, global sales of Cozaar and Hyzaar totaled $3.
5 mg of hydrochlorothiazide (HCTZ) or substitute with Hyzaar 50-12.
Those included asthma and allergy pill Singulair, diabetes pills Januvia and Janumet, and blood pressure pills Cozaar and Hyzaar.
These increases were partially offset by expected declines in sales of COZAAR (losartan potassium) and HYZAAR (losartan potassium and hydrochlorothiazide) as well as European austerity measures.
Accupril, Actosm, Advair Disku, Allegra-D, Alphagan-P, Aricept, Arimidex, Avalide, Avandia,Avapro, Casodex, Celexa, Clarinex, Coumadin, Cozaar, Depakote, Detrol LA, Diovan, Exelon, Flonase, Flovent, Fosamax, Glucophage XR, Hyzaar, Lamictal, Lipitor, Mirapex, Mobic, Nasonex, Neurontin, Paxil, Pravachol, Premarin, Prempro, Prevacid, Prograf, Proscar, Risperdal, Serevent, Singulair, Synthroid, Topamax, Vioxx, Xalatan, Zocor and Zyrtec -- should be particularly alert to the potential for manufacturer-created shortages.
The prescription medications encompassed in the RFA "Canadian Drug Savings Calculator" are Accupril, Actosm, Advair Disku, Allegra-D, Alphagan-P, Aricept, Arimidex, Avalide, Avandia, Avapro, Casodex, Celexa, Clarinex, Coumadin, Cozaar, Depakote, Detrol LA, Diovan, Exelon, Flonase, Flovent, Fosamax, Glucophage XR, Hyzaar, Lamictal, Lipitor, Mirapex, Mobic, Nasonex, Neurontin, Paxil, Pravachol, Premarin, Prempro, Prevacid, Prograf, Proscar, Risperdal, Serevent, Singulair, Synthroid, Topamax, Vioxx, Xalatan, Zocor and Zyrtec.
The increase was primarily due to sales of generic versions of Yaz, Cozaar, Hyzaar and Skelaxin launched in the second quarter 2010, as well as sales of new products launched late in 2009 and the first quarter 2010.
DuPont's Cozaar and Hyzaar drugs patent expired this quarter, which affected profits by 13 cents.